Uroclinic SRL
1.0 FTEUroclinic reported total assets of 163,387 € at the end of the 2025 financial year (annual accounts filed with the NBB on 19 Jan 2026), with 1 full-time equivalent.
The score of Uroclinic shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -46 % Total assets +19 % Headcount (avg FTE) 0 %
Accounts of the company itself (not consolidated).
The full file covers 6 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Uroclinic's annual accounts
Filed annual accounts
- Year ended 30 Jun 2025filed on 19 Jan 2026
- Year ended 30 Jun 2024filed on 03 Feb 2025
- Year ended 30 Jun 2023filed on 26 Dec 2023
- Year ended 30 Jun 2022filed on 10 Jan 2023
- Year ended 30 Jun 2021filed on 28 Jan 2022
Uroclinic's financial analysis
- Solvency42.7%sector median: 72.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Uroclinic
Uroclinic's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0719.559.460
- VAT number
- BE0719559460
- Peppol
- Registered · 0208:0719559460 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 29 Jan 2019
- Registered office
- 3080 Tervuren
- Size
- Micro · 1.0 FTE
- Latest accounts
- 2025 · filed on 19 Jan 2026
- Activity
- Medical specialists activities (NACE 86220)
Uroclinic (SRL) has been based in Tervuren since 2019, active in: medical specialists activities. For 2025, it reports a net profit of 7,822 € and equity of 69,779 €; its revenue is not published. With 1.0 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 42.7%, below the median of its sector (72.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Uroclinic
Companies in the same business, of comparable size and area, outside its group.
- Cabinet de Pneumologie du Professeur CORHAY JL Medical specialists activities Herve · balance sheet 163,266 €
- Dokter Hendrickx Anne-Maria Medical specialists activities Wetteren · balance sheet 163,252 €
- DR.K.Quirijnen Medical specialists activities Wemmel · balance sheet 163,251 €
- Moro Cassiano Medical specialists activities Saint-Hubert · balance sheet 163,543 €
- Docteur Fernande Lois Medical specialists activities Walhain · balance sheet 163,054 €
- Centre de Médecine Intégrative Medical specialists activities Assesse · balance sheet 162,927 €
- Medicos Medical specialists activities Antwerp · balance sheet 162,831 €
- ECS Ortho Medical specialists activities Ham-sur-Heure-Nalinnes · balance sheet 164,054 €
Frequently asked questions about Uroclinic
What is the revenue of Uroclinic?
Uroclinic files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Uroclinic?
In Belgium, the VAT number is the company number prefixed with BE: BE0719559460 for Uroclinic, if the company is VAT-registered. Its company number (CBE) is 0719.559.460.
Where is the registered office of Uroclinic?
According to the CBE register, the registered office of Uroclinic is in 3080 Tervuren.
What is the equity of Uroclinic?
At the close of the 2025 financial year, the equity of Uroclinic amounts to 69,779 €, a solvency of 42.7% of total assets.
How many people work at Uroclinic?
1.0 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Uroclinic?
The register lists 1 active mandates at Uroclinic. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Uroclinic
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →